Study of SKI-O-703 in healthy adults after a meal
Part of Blood & lymphatic, Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests whether the body processes SKI-O-703 the same way in healthy Korean and Caucasian adults when taken with food. It helps determine the correct dosing for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 or older and of Korean or Caucasian background
- Your body mass index (BMI) is between 18 and 30 and you weigh at least 50 kg
- You are in good health based on a physical exam and lab tests
- You are able to swallow multiple capsules
- You have not taken any experimental drugs in the last month or participated in another trial in the last 6 months
- You are not a smoker and have not used nicotine products in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new biosimilar medicine (CKD-704) to see how it compares to the approved Skyrizi treatments for healthy adults. It checks how the medicine moves through the body, its safety, and how the immune system responds.
This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.
This study tests a new tablet, HL40626S, in healthy volunteers to understand its safety and how the body processes it. If you are a healthy adult, you may be able to help researchers gather important information for future treatments.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.
Hear when a new Immune Thrombocytopenia (ITP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.